Absolute DXS delivers results with 97.7% sensitivity for fast, accurate reporting and our rapid turnaround expedites ID and AST processes. as well as providing the opportunity to reduce broad spectrum antibiotic consumption. Absolute DXS supports clinicians ability to target antibiotic therapy to treat specific bacterial infection and to improve infection control practices for earlier patient discharge.
Utilizing advanced Urine analyzers and reagent strip combinations, Absolute DXS detects pathogenic and nonpathogenic bacterial species. Additionally, these techniques can also define many of the genes associated with antibiotic resistance.